0001209191-21-004769.txt : 20210121
0001209191-21-004769.hdr.sgml : 20210121
20210121210012
ACCESSION NUMBER: 0001209191-21-004769
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210119
FILED AS OF DATE: 20210121
DATE AS OF CHANGE: 20210121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HILL NANCY LOUISE
CENTRAL INDEX KEY: 0001780790
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38957
FILM NUMBER: 21543526
MAIL ADDRESS:
STREET 1: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION
STREET 2: 1551 EASTLAKE AVE E STE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp
CENTRAL INDEX KEY: 0001478320
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270907024
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-659-0067
MAIL ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptive TCR Corp
DATE OF NAME CHANGE: 20091209
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-19
0
0001478320
Adaptive Biotechnologies Corp
ADPT
0001780790
HILL NANCY LOUISE
C/O ADAPTIVE BIOTECHNOLOGIES CORP.
SUITE 200
SEATTLE
WA
98102
0
1
0
0
EVP, Operations & Program Mana
Common Stock
2021-01-19
4
M
0
2000
0.84
A
12000
D
Common Stock
2021-01-19
4
M
0
23000
4.07
D
35000
D
Common Stock
2021-01-19
4
S
0
25000
69.00
D
10000
D
Common Stock
500
I
By Ryan Hill (son)
Common Stock
400
I
By Brandon Hill (son)
Common Stock
300
I
By Connor Hill (son)
Stock Option (Right to Buy)
0.84
2021-01-19
4
M
0
2000
0.00
D
2023-11-03
Common Stock
2000
0
D
Stock Option (Right to Buy)
4.07
2021-01-19
4
M
0
23000
0.00
D
2025-04-17
Common Stock
23000
27000
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
The option is fully vested and exercisable.
/s/ Nancy Hill by Eric Billings, Attorney-in-Fact
2021-01-21